Beat Loan Growth & Credit Costs; CapEx Timing Inflates Q1 Profit
Ujjivan beat loan growth and halved credit cost guidance in Q1, but reported profit is inflated by a ₹250 crore capacity spend shifted to Q2–Q4. The real story — and the real test — is sustaining ROA above 1.8% amid rising margin pressures.
₹317 Cr
+206.7% YoY
2.2%
inflated by ₹250 Cr capex deferral
1.8–2%
reflects full-year capex spend
Ujjivan's earnings look exceptional on the surface — PAT up 206.7% year-on-year — but the call reveals a timing story beneath. The bank deferred ₹250 crore in planned capacity spending (branch expansion, technology, branding) from Q1 to Q2 onwards, artificially suppressing Q1 opex and inflating reported profit. Strip away that benefit, and you find a solid but not exceptional organic quarter: the real story is the credit cost beat and loan growth beat, backed by concrete data (99.7% collection, slippages down 40%, loan growth tracking 28.9% vs 25% target), with guidance raised on ROA and deposit mobilization proving strong.
What actually beat — and by how much
Loan growth 28.9%, beating 25% FY27 guidance
SupportedGross loan book ₹42,903 Cr (+28.9% YoY). Already tracking well ahead of full-year target.
Credit costs 0.9%, halving prior 1.4–1.5% guidance
SupportedCredit costs ₹127 Cr = 0.9% of ATA. Full-year guidance revised down to 0.9–1%. Structural, not cyclical.
Deposit growth 25% YoY, highest in couple of years
SupportedDeposits ₹48,129 Cr (+25% YoY). CASA ₹12,930 Cr (+37.8%). Both claims match reported data.
NIM stable at 8.5%, cost of funds improved
SupportedNII ₹1,186 Cr, NIM 8.5% maintained. Cost of funds 6.86%. Confirmed despite ongoing deposit competition.
Secured portfolio tracking to 56% mix by Mar-27
SupportedSecured ₹21,638 Cr (50.4% of book, +42.7% YoY). On track; 5.6 percentage points to target by year-end.
Collection efficiency and slippages both strengthen
SupportedBucket X 99.7% confirmed; slippages 1.72% annualized, down from 2.68% Q4. 40% reduction QoQ validated.
What changed on this call — guidance revisions
ROA +20 bps — raised from 1.6% to 1.8–2%. Credit cost outperformance (0.9% vs 1.4–1.5%) and capex deferral improve FY27 opex ratio.
Credit cost −60 bps — cut from 1.4–1.5% to 0.9–1%. Microfinance slippages down 40% QoQ; collection at 99.7% structurally sound across all states.
Opex ratio to 6.4% ATA — improved from earlier plan. ₹250 Cr capacity spend deferred; H1 benefit will normalize Q2 onwards.
Loan growth 25% FY27 reaffirmed — but Q1 already tracking 28.9%, suggesting upside or front-loading. Guidance remains conservative.
NIM 8.5% reaffirmed — stable despite deposit cost pressures and tight market liquidity. IBPC, securitization, FCNR (₹60 Cr mobilized Q1) provide funding optionality.
The bull-bear ledger
Loan growth beat (28.9% vs 25%) on back of secured portfolio acceleration (+42.7% YoY); mix shift on track
Credit costs halved; microfinance slippages down 40%, collection at 99.7% — structural improvement, not cyclical bounce
CASA franchise strong (+37.8% YoY), highest deposit growth in 2 years; targeting 30% ratio sustainability
Q1 PAT inflated by ₹250 Cr capex deferral; underlying organic profit materially lower than reported
Yield compression in MSME deliberate strategy (11.5% → 10.5%) to chase higher volumes; opex savings don't fully offset yield loss
Deposit cost inflation ongoing; NIM stability depends on rigorous COF management and product mix discipline
Macro headwinds: El Niño, kharif crop delay risk to MFI demand; H2 FY27 is a real test of 99.7% collection hold
New products (gold loans, pre-owned cars, mid-corporate) still early-stage; rapid growth from small base not yet validated at scale
Market positioning — how the street is reading this
The market approved Q1 with a day-1 pop of +2.82% (delivery 42.6%), a solid endorsement of the print. However, the stock is priced for near-perfection: trading at ₹71.57, only 2.12% below its all-time high of ₹73.12, up 51.28% from its 52-week low of ₹47.31. Momentum is overbought (RSI 74.8), and the stock sits above its 20-day, 50-day, and 200-day moving averages. Institutionally, FII ownership rose 1.78 percentage points (now 17.23%) and DII rose 2.45 percentage points (now 31.13%) in the most recent quarter — both are adding, a sign of confidence — but the stock's positioning leaves little room for disappointment. Any failure to deliver on the 1.8–2% ROA guidance, or a miss on deposit cost management or credit quality, could trigger a sharp pullback from these levels.
Risks ranked by severity to a holder
Deposit cost inflation accelerates faster than NIM guidance assumes
MediumRBI repo at 5.25%; liquidity tight. Management guided only 'marginal' COF increase. If deposit rates rise faster, NIM compression accelerates and the 1.8–2% ROA target misses.
Yield compression from MSME upmarket migration proves unsustainable
MediumMSME yields down from 11–11.5% to 10.5% due to conscious ticket-size migration. Management says opex offsets, but if higher-ticket MSME shows credit deterioration or competitive yield pressure intensifies, ROA expansion stalls.
El Niño / kharif crop failure impacts MFI demand and repayment
MediumMicrofinance is ~50% of portfolio. A crop failure or agricultural distress in H2 could pressure both demand and collection rates, despite today's impressive 99.7% bucket X collection.
CapEx execution slippage into Q3–Q4 extends opex drag into FY28
Low₹250 Cr spend deferred; if further slippage occurs, FY27 opex ratio benefits extend and FY28 normalizes higher, creating an earnings miss surprise in next year.
New products fail to scale or show credit deterioration at higher volumes
LowGold loans +248.6% from ₹300 Cr base; pre-owned cars only piloted in one state; mid-corporate just started. Unproven at scale; if credit stress emerges, growth targets miss.
The debate
1 · Q2–Q4 capex spending pace and opex ratio normalization
₹250 Cr capacity spend expected Q2 onwards. Monitor quarterly opex spend and the path to 6.4% ATA guidance. If execution slips or opex normalizes higher than guided, FY27 ROA forecast falls short of 1.8–2%.
2 · Kharif crop sowing outcome and MFI collection trend
H2 FY27 is a macro test. If kharif sowing delays or agricultural stress emerges, MFI collection efficiency (today 99.7%) could deteriorate. This is the single largest risk to the credit cost guidance (0.9–1%) holding.
3 · Secured portfolio progress toward 56% target by Mar-27
Currently 50.4%, target 56%. Execution on mix shift validates diversification strategy away from MFI concentration. Track quarterly progress; if it stalls, ROA expansion is constrained.
4 · Deposit cost trend and NIM sustainability in Q2–Q3
Cost of funds 6.86% today. If competitive intensity in CASA/bulk deposits accelerates, COF rises faster than NIM guidance prices. Watch quarterly COF and NIM trajectory closely.
Ujjivan is a solid franchise with genuine credit quality improvement and deposit momentum. Q1 beat on the hard metrics — loan growth, credit costs, CASA, collection — is real and validated. But reported profit is inflated by capex timing, and margin pressures from yield compression and deposit cost inflation are structural headwinds that require disciplined management. The 1.8–2% ROA guidance is achievable but not a given.
The street has rewarded the quarter (+2.82% day 1) and the stock is up 51% from its low, now overbought and near all-time highs. Institutional flows are positive (FII +1.78pp, DII +2.45pp), but valuations leave no room for stumbles. The number to track from here is organic ROA — not the inflated Q1 2.2%, but the guided FY27 1.8–2% — and how management navigates deposit costs and yield pressures to sustain it. Hold for believers in the credit quality story; wait for a pullback for new entries.
Informational and educational content only. Not investment advice.